Current Issue

View Larger Image

Past Issues Adlink Subscription Visit Our Publisher

ADVERTISEMENT



Top Keywords




GEN podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

BIOTECHNOLOGY IN GEORGIA

4/16/2009

- Interview with Charles Craig, President of Georgia Bio; Stephen Hill, President, Solvay Pharmaceuticals, Inc.; and Russell Medford, M.D., Ph.D., President and CEO, Atherogenics, Inc.

The Biotechnology Industry Organization's (BIO) annual International Conference will take place in Atlanta this year on May 18–21. The conference committee made its decision to hold the meeting in Atlanta based on a number of factors. For example, Georgia’s life science community is a mix of companies applying life science technologies to improving medicine, healthcare, agriculture, industrial and energy production, forestry, marine science, and environmental management. There are more than 300 life science companies in the state, most focused on healthcare applications, ranging from established to start-up pharmaceutical, biotechnology, medical device, diagnostic, medical supply, and medical informatics companies as well as contract laboratories and preclinical and clinical research organizations.


During this week's podcast three professionals closely allied to life science activities in Georgia explain why the state is an attractive location for a biotech company to set up shop. They discuss the life science academic infrastructure and provide additional details on the specific types of biotech and pharmaceutical companies working in the state.


Dr. Russell Medford, co-chair of the BIO 2009 conference steering committee, Charles Craig, member of the conference executive committee, and Stephen Hill, member of the conference steering committee describe the major advantages of doing business in Georgia and expand on the main themes for the Atlanta Convention.





Related content

GEN News Highlights

MORE RELATED GEN NEWS HIGHLIGHTS

Insight & Intelligence™

MORE RELATED INSIGHT & INTELLIGENCE™

GEN Articles

MORE RELATED GEN ARTICLES

BLOG biotech

MORE RELATED BLOG BIOTECH

GEN Podcasts

MORE RELATED GEN PODCASTS

Subscription center

BACK TO TOP

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe
e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.
 

All fields are required
Email
Confirm Email
First Name
Last Name
Organization
E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

GEN webinars

« View All Webinars »

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Funding Early-Stage Companies

How much do you think newly established funds will succeed in helping startups?

Suggest a Poll
« More »     « View Results »     « Poll Archive »